Specialty Vaccine Company PaxVax, Inc. Expands Global Commercial Team
PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the expansion of its global commercial team with the appointments of Jonathan Klock as Vice President of Sales and Marketing, North America; Jeremy Gowler as Vice President of Global Marketing; and five U.S. National Account Directors. They join the European and U.S.-based commercial teams who came to PaxVax in conjunction with the company's acquisition of the oral typhoid vaccine Vivotif® last month.